Project Grant G2649889

This federal Project Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Congressional Directives program (CFDA 93.493) provides $3,900,000 to the University of New Mexico Health Sciences Center (UNM HSC) to expand the NOWS-NM quality improvement (QI) program. The program aims to optimize care and reduce unnecessary infant transports for neonates with neonatal opioid withdrawal syndrome (NOWS) by providing training and QI coaching to healthcare...

This Project Grant award, with a total funding of $180,059, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award supports a study titled "Optimizing Developmental Outcomes in Early Childhood After Neonatal Opioid Withdrawal Syndrome" at the Research Institute at Nationwide Children's Hospital (RINCH), a prominent non-profit research organization. The key objectives of this study are to: 1) engage with...

The U.S. Department of Health and Human Services, through the Health Resources and Services Administration's (HRSA) Rural Health Research Centers program (CFDA 93.155), awarded a $2,250,000 project grant to Southern Healthcare Collaboration, Inc., a non-profit organization based in Baxley, Georgia. The grant, awarded on September 1, 2024, with a performance period through August 31, 2028, will support the organization's "Rural Communities Opioid Response Program-IMPACT" initiative....

This $1,016,264 Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to develop and evaluate digital screening and brief intervention (e-SBI) approaches for addressing perinatal substance use in home visiting programs. The project, led by the non-profit organization Partnership To End Addiction, will pilot test three e-SBI delivery strategies - a single session, a session plus booster, and post-session text...

The U.S. Department of Health and Human Services, through the Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment, awarded a $55,500,000 Project Grant (CFDA 93.243) to the American Academy of Addiction Psychiatry (AAAP) and its collaborative partners. The grant, titled "Opioid Response Network: Collaborating, Advancing, Responding, Educating (CARE Team)", will provide training and technical assistance to address opioid use disorder,...

This federal Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $411,800 to Rekovar Inc., a woman-owned small business in California, to develop the NeoMonki system - a wireless wearable device with AI analytics for monitoring Neonatal Abstinence Syndrome (NAS). The key products and services to be delivered include: A comprehensive NAS monitoring kit consisting of wearable biosensor wristbands, a...

This $100,000 Project Grant award from the Health Resources and Services Administration's (HRSA) Rural Health Care Services Outreach, Rural Health Network Development and Small Health Care Provider Quality Improvement Program (CFDA 93.912) will fund the development of the Stanly Substance Use Network (SUN) in Stanly County, North Carolina. The SUN will establish a multi-sector collaborative system of care to improve access to and quality of basic health services, including primary care,...

This $945,397 federal Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) aims to adapt and evaluate a Collaborative Care Model (CCM) for treating pregnant and postpartum persons with opioid use disorder (OUD) in low-resource obstetric settings. The key objectives are to: 1) adapt an existing CCM for rural and low-resource obstetric sites; 2) create a common data model to harmonize data across study sites; 3)...

The federal Project Grant award of $3,000,000 was provided by the Health Resources and Services Administration (HRSA) under the Rural Health Research Centers program (CFDA 93.155). The grant was awarded to Baptist Healthcare System Inc., a non-profit healthcare provider based in Corbin, Kentucky, on September 1, 2024, with a performance period ending on August 31, 2028. The grant funding will support the "RURAL COMMUNITIES OPIOID RESPONSE PROGRAM-IMPACT" initiative, which aims to...

This federal Project Grant award in the amount of $1,499,606 was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The award was made to the Dartmouth-Hitchcock Clinic, a non-profit healthcare provider and academic medical center located in Lebanon, New Hampshire. The project aims to characterize health outcomes from birth to 5 years of age in children born to people with opioid use disorder, identify disparities among...